Freshpet
FRPT
$71.47
+14.57%
Freshpet, Inc. produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores, primarily targeting dogs. As a pioneer in the fresh pet food category, Freshpet has carved out a distinct niche as a high-growth disruptor within the packaged foods industry, leveraging a unique distribution model and a strong brand focused on natural, refrigerated pet nutrition. The current investor narrative centers on the company's ability to sustain its growth trajectory amid a challenging consumer environment, with attention on margin expansion as the company scales, recent profitability improvements, and the potential for market share gains as pet owners increasingly seek fresher alternatives.…
FRPT
Freshpet
$71.47
FRPT 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Freshpet's 12-month outlook, with a consensus price target around $81.50 and implied upside of +14.0% versus the current price.
Average Target
$81.50
0 analysts
Implied Upside
+14.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$62 - $104
Analyst target range
Freshpet is covered by 16 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.53 (where 1 is Strong Buy and 5 is Sell). The average target price is $81.25, implying approximately 41.2% upside from the current price of $57.54. The distribution leans bullish, with no sell ratings and a majority of buy or overweight ratings, including recent affirmations from Benchmark (Buy), Oppenheimer (Outperform), and Wells Fargo (Overweight).
The target price range spans from a low of $62.00 to a high of $104.00, representing a wide spread of $42.00, which indicates significant uncertainty about the company's future performance. The high target of $104.00 assumes strong growth acceleration and margin expansion, while the low target of $62.00 prices in potential headwinds such as competition or slower adoption. Recent rating actions have been mostly positive, with upgrades from Morgan Stanley (Overweight from Equal Weight) and Oppenheimer (Outperform from Perform), suggesting improving sentiment among analysts.
Bulls vs Bears: FRPT Investment Factors
Freshpet presents a compelling growth story with strong revenue growth, improving profitability, and a solid balance sheet. The bull case is supported by a PEG ratio of 0.11, which suggests undervaluation relative to growth, and a consensus analyst target implying 41% upside. However, the bear case highlights decelerating revenue growth, a high forward P/E of 32.1x, and extreme stock volatility. The single most important tension is whether Freshpet can sustain its growth trajectory and margin expansion to justify its premium valuation. If growth reaccelerates or margins continue to improve, the stock could re-rate higher; if growth slows further or competition intensifies, the stock could face significant downside. Currently, the evidence slightly favors the bulls given the attractive PEG ratio and improving fundamentals, but the high volatility and growth deceleration warrant caution.
Bullish
- Strong Revenue Growth Trajectory: Freshpet's Q4 2025 revenue of $285.2 million grew 8.6% YoY, significantly outpacing the packaged foods industry average of 2-3%. The company has sustained double-digit growth rates over the past two years, demonstrating strong demand for its fresh pet food products.
- Improving Profitability and Margins: Gross margin expanded from 30.3% in Q1 2023 to 36.8% in Q4 2025, while operating margin turned positive at 18.3% in Q4 2025. Net income of $33.8 million in Q4 2025 represents a sharp turnaround from a loss of $12.7 million in Q1 2025, showcasing significant operating leverage.
- Strong Balance Sheet and Cash Flow: Freshpet has a current ratio of 5.54 and a debt-to-equity ratio of 0.46, indicating low financial risk. Free cash flow was $109.6 million in Q4 2025, a dramatic improvement from negative free cash flow in prior quarters, providing financial flexibility for growth investments.
- Attractive Valuation Relative to Growth: The PEG ratio is 0.11, suggesting the stock is undervalued relative to its earnings growth rate. The trailing P/E of 21.4x is near the low end of its historical range, and the price-to-sales ratio of 2.7x is also near historical lows, potentially offering a value opportunity.
Bearish
- Decelerating Revenue Growth: Revenue growth decelerated from 17.7% YoY in Q1 2024 to 8.6% in Q4 2025. This slowdown raises concerns about market saturation or increased competition, and if growth continues to decelerate, the premium valuation may compress.
- High Forward P/E Multiple: The forward P/E of 32.1x represents a 28-60% premium to the packaged foods industry average of 20-25x. This implies high expectations for future earnings growth, leaving the stock vulnerable to disappointment if margins or growth falter.
- Significant Stock Volatility: With a beta of 1.605, Freshpet is 60.5% more volatile than the S&P 500. The stock has experienced a max drawdown of -44.57% and is down 19.8% over the past year, indicating substantial downside risk during market downturns.
- Single-Product Category Risk: Freshpet derives all revenue from fresh pet food, with no diversification across product lines. This concentration exposes the company to category-specific risks such as changing consumer preferences, supply chain disruptions, or regulatory changes in pet food safety.
FRPT Technical Analysis
Freshpet is in a sustained downtrend over the past year, with the stock price declining 19.8% over the last 12 months. The current price of $57.54 sits at 67% of its 52-week range (low $46.45, high $86.00), indicating the stock is closer to the bottom of its range, which could suggest a value opportunity but also reflects persistent selling pressure. The 52-week low was set in May 2026 at $46.45, and the stock has since recovered about 24% from that level, but remains well below the 52-week high of $86.00.
Short-term momentum shows a mixed picture: the 1-month price change is +9.1%, suggesting a recent bounce, while the 3-month change is -13.0%, indicating that the longer-term downtrend remains intact. This divergence—positive one-month momentum against a negative three-month trend—could signal a potential short-term reversal or a temporary pullback within a larger downtrend. The stock's beta of 1.605 implies it is 60.5% more volatile than the S&P 500, amplifying both upside and downside moves.
Key support lies at the 52-week low of $46.45, while resistance is at the 52-week high of $86.00. A breakout above $86.00 would signal a major trend reversal, while a breakdown below $46.45 could lead to further downside. The stock's high beta (1.605) means it is significantly more volatile than the market, which is important for risk management and position sizing.
Beta
1.64
1.64x market volatility
Max Drawdown
-44.6%
Largest decline past year
52-Week Range
$46-$86
Price range past year
Annual Return
+6.0%
Cumulative gain past year
| Period | FRPT Return | S&P 500 |
|---|---|---|
| 1m | +32.1% | +2.5% |
| 3m | +27.9% | +5.2% |
| 6m | +2.2% | +11.5% |
| 1y | +6.0% | +22.6% |
| ytd | +18.8% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FRPT Fundamental Analysis
Freshpet's revenue trajectory remains robust, with the most recent quarter (Q4 2025) reporting revenue of $285.2 million, representing 8.6% year-over-year growth. Over the trailing four quarters, revenue has grown from $223.8 million (Q1 2024) to $285.2 million, indicating a steady upward trend, though growth has decelerated from the 17.7% YoY growth seen in Q1 2024. The company's single reportable segment (fresh pet food) drives all revenue, with no diversification by product line, making it entirely dependent on the fresh pet food category.
The company turned profitable in recent quarters, with net income of $33.8 million in Q4 2025, compared to a loss of $12.7 million in Q1 2025. Gross margin has improved from 30.3% in Q1 2023 to 36.8% in Q4 2025, reflecting better cost management and scale. Operating margin also improved to 18.3% in Q4 2025 from negative levels in early 2023, demonstrating significant operating leverage. The net margin of 11.9% in Q4 2025 is healthy for the packaged foods industry.
Freshpet maintains a strong balance sheet with a current ratio of 5.54 and a debt-to-equity ratio of 0.46, indicating low financial risk. Free cash flow was $109.6 million in Q4 2025, a sharp improvement from negative free cash flow in prior quarters, showing the business is now generating cash. Return on equity (ROE) stands at 11.5%, reflecting efficient use of equity capital. The company has no dividend, reinvesting all profits into growth.
Quarterly Revenue
$285229000.0B
2025-12
Revenue YoY Growth
+8.6%
YoY Comparison
Gross Margin
36.8%
Latest Quarter
Free Cash Flow
$160561000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FRPT Overvalued?
Since Freshpet has positive net income ($33.8 million in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E is 21.4x, while the forward P/E is 32.1x, implying the market expects earnings to grow significantly. The gap between trailing and forward P/E suggests that analysts anticipate a sharp increase in earnings, which is consistent with the company's improving profitability trajectory.
Compared to the packaged foods industry, Freshpet trades at a premium. The industry average P/E is typically around 20-25x, but Freshpet's forward P/E of 32.1x represents a 28-60% premium. This premium is justified by Freshpet's superior growth rate (8.6% YoY revenue growth vs. industry average of 2-3%) and expanding margins. However, the PEG ratio of 0.11 suggests the stock is undervalued relative to its growth rate, indicating that the market may not be fully pricing in future earnings growth.
Historically, Freshpet's trailing P/E has ranged from negative (when unprofitable) to over 100x. The current trailing P/E of 21.4x is near the low end of its historical range, which could indicate a value opportunity if the company's growth trajectory continues. However, the forward P/E of 32.1x is more elevated, reflecting optimism about future earnings. The stock's price-to-sales ratio of 2.7x is also near historical lows, suggesting the market is not assigning a high premium to sales growth currently.
PE
21.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~139x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Freshpet's primary financial risk is its dependence on sustained revenue growth to justify its forward P/E of 32.1x. While the company turned profitable in Q4 2025 with net income of $33.8 million, the net margin of 11.9% is still below the industry average for mature packaged food companies. The company has no dividend, so investors rely entirely on capital appreciation. Additionally, the debt-to-equity ratio of 0.46 is moderate, but interest expense of $3.4 million in Q4 2025 could become a burden if rates rise or earnings decline. The free cash flow improvement to $109.6 million is positive, but it is volatile and may not be sustainable if growth investments increase.
Market & Competitive Risks: Freshpet trades at a significant premium to the packaged foods industry, with a forward P/E of 32.1x vs. an industry average of 20-25x. This premium makes the stock vulnerable to multiple compression if growth disappoints. The stock's beta of 1.605 indicates high sensitivity to market movements, and the 19.8% decline over the past year underperformed the S&P 500's 16.5% gain. Competition from traditional pet food companies (e.g., Nestlé, Mars) and other fresh pet food startups could pressure market share. Regulatory risks include potential changes in FDA guidelines for pet food safety or labeling, which could increase costs.
Worst-Case Scenario: In a severe downturn, Freshpet could face a combination of decelerating growth (below 5%), margin compression from competition, and a market-wide sell-off. The stock could retest its 52-week low of $46.45, representing a 19.3% decline from the current price of $57.54. If the company reports a loss again or guidance disappoints, the stock could fall further to the analyst low target of $62.00, but that is above the current price. A more realistic worst-case scenario is a drop to $46.45, implying a -19.3% loss. Historically, the max drawdown was -44.57%, so a decline to $31.90 is possible in a severe bear case, but that would require a fundamental deterioration.